Dankmar Böhning (2015).  Power series mixtures and the ratio plot with applications to zero-truncated count distribution modelling. Metron 73:201–216. DOI 10.1007/s40300-015-0071-6.

 

Heinz Holling, Walailuck Böhning,  and Dankmar Böhning (2015). The Covariate-Adjusted Frequency Plot for the Rasch Poisson Counts Model.  The Thailand Statistician 13, 67–78.

 

Dankmar Böhning, Kalliopi Mylona, and Alan Kimber (2015).  Meta-Analysis of Clinical Trials with Rare Events. Biometrical Journal 57, 633-648. [ Supplement ]

 

Richard I. G. Holt,  Walailuck Böhning, Nishan Guha, Christiaan Bartlett, David A. Cowan, Sylvain Giraud, E. Eryl Bassett, Peter H. Sönksen, and Dankmar Böhning (2015). The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays. Drug Testing and Analysis 7, 745-755. Article first published online : 21 JAN 2015, DOI: 10.1002/dta.1772. 

 

Dankmar Böhning (2015). Youden’s Index and the Likelihood Ratio Positive in Diagnostic Testing. Methods of Information in Medicine 54: 382-383. http://dx.doi.org/10.3414/ME15-04-0004

 

Dankmar Böhning and Peter van der Heijden (2015).  Correspondence: Some general points regarding Ledberg and Wennberg, BMC Medical Research Methodology 2014 April 27;14:58. Medical Research Methodology 15:51.

 

Peter G.M. van der Heijden, Ieke de Vries, Dankmar Böhning and Maarten Cruyff (2015).   Estimating the size of hard-to-reach populations using capture-recapture methodology, with a discussion of the International Labour Organization’s global estimate of forced labour. Forum on Crime and Society, Special Issue on Researching hidden populations: approaches to and methodologies for generating data on trafficking in persons. Ed. by Kristina Kangaspunta, United Nations Office on Drug and Crime, New York, United Nations, 109-136.

 

Nishan Guha, Simon P Nevitt,  Michael Francis, John A Woodland, Dankmar Böhning, Peter H. Sönksen, and  Richard I. G. Holt (2015). The Effects of Recombinant Human Insulin-like Growth Factor-I/Insulin-like Growth Factor Binding Protein-3 Administration on Body Composition and Physical Fitness in Recreational Athletes. J Clin Endocrinol Metab doi: 10.1210/jc.2015-1996.